J.D. (Joshua) Elford MSc

Pharmacology
j.d.elford@uu.nl

Publications

2026

Scholarly publications

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez Pardo, P. (2026). Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis. npj Parkinson's Disease, 12(1), Article 31. [DOI] [Portal]

2024

Scholarly publications

Elford, J. D., Becht, N., Garssen, J., Kraneveld, A. D., & Perez-Pardo, P. (2024). Buty and the beast: the complex role of butyrate in Parkinson’s disease. Frontiers in Pharmacology, 15, Article 1388401. [DOI] [Repository]
Markidi, A., Elford, J. D., Berkers, C., Kraneveld, A. D., & Perez-Pardo, P. (2024). Gut Microbes in Parkinson's Disease. In The Gut-Brain Axis: Dietary, Probiotic, and Prebiotic Interventions on the Microbiota (2 ed., pp. 217-240) [DOI]

2023

Scholarly publications

Cui, H., Elford, J. D., Alitalo, O., Perez-Pardo, P., Tampio, J., Huttunen, K. M., Kraneveld, A., Forsberg, M. M., Myöhänen, T. T., & Jalkanen, A. J. (2023). Nigrostriatal 6-hydroxydopamine lesions increase alpha-synuclein levels and permeability in rat colon. Neurobiology of Aging, 129, 62-71. [DOI] [Repository]